SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-021062
Filing Date
2018-08-09
Accepted
2018-08-09 16:16:57
Documents
62
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q enta-10q_20180630.htm 10-Q 2091792
2 EX-31.1 enta-ex311_8.htm EX-31.1 16203
3 EX-31.2 enta-ex312_6.htm EX-31.2 16189
4 EX-32.1 enta-ex321_7.htm EX-32.1 8926
5 GRAPHIC gmzggre22yla000001.jpg GRAPHIC 43069
  Complete submission text file 0001564590-18-021062.txt   7386854

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT enta-20180630.xml EX-101.INS 1824129
7 XBRL TAXONOMY EXTENSION SCHEMA enta-20180630.xsd EX-101.SCH 41327
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enta-20180630_cal.xml EX-101.CAL 41917
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enta-20180630_def.xml EX-101.DEF 132516
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20180630_lab.xml EX-101.LAB 308398
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20180630_pre.xml EX-101.PRE 263032
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 181005251
SIC: 2834 Pharmaceutical Preparations